Welcome to our dedicated page for Enpro news (Ticker: $NPO), a resource for investors and traders seeking the latest updates and insights on Enpro stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Enpro's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Enpro's position in the market.
Enpro Inc. (NYSE: NPO) reported its First Quarter 2024 Results, with sales of $257.5 million down 8.9% compared to the prior-year period. GAAP income from continuing operations was $12.5 million, Adjusted EBITDA down 14.9% to $58.4 million, and adjusted diluted earnings per share from continuing operations down 19.5% to $1.57. The acquisition of AMI was completed in January 2024. Full year 2024 guidance includes revenue growth of low-to-mid single digits, adjusted EBITDA of $260-$280 million, and adjusted diluted earnings per share in the range of $7.00 to $7.80.
Enpro Inc. (NYSE: NPO) has announced a regular quarterly dividend of $0.30 per share payable on June 20, 2024, to shareholders of record as of June 5, 2024.
Enpro Inc. (NYSE: NPO) will be presenting at the Oppenheimer 19th Annual Industrial Growth Conference on May 9, 2024. The presentation will be conducted virtually by the President, CEO, and CFO at 9:00 a.m. Eastern Time.
